- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
top
The successful development of effective HIV preventive interventions requires a large international cooperative effort drawing on partners from health sectors, inter-governmental organizations, government, research institutions, industry, and affected populations. It also requires these partners to address the difficult ethical concerns that arise during the development of biomedical HIV prevention products. UNAIDS published this update to a guidance document on ethical considerations in HIV preventive vaccine research in 2007, with further refinements in 2012. This publication reflects numerous consultations and other developments related to the conduct of biomedical HIV prevention trials, including vaccine trials.